Spla2 inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S427000

Reexamination Certificate

active

06916840

ABSTRACT:
A novel class of benz[g]indole compounds is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of Inflammatory Diseases such as septic shock.

REFERENCES:
patent: 0 620 215 (1994-10-01), None
patent: 0 675 110 (1995-10-01), None
patent: WO 00/37358 (2000-06-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Spla2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Spla2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spla2 inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3420608

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.